Get started
Award

82172982

Funded outputs count: 8
Funder award ID: 82172982
OpenAlex ID: G2616634427
MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
2025 · Tianyu Qu, Lei Song, et al. · Cancer Research · 16
Multi-omics analysis reveals NNMT as a master metabolic regulator of metastasis in esophageal squamous cell carcinoma
2024 · Qi Huang, Haiming Chen, et al. · npj Precision Oncology · 33
PDF
B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma
2023 · Yanan Cui, Jun Li, et al. · Journal of Experimental & Clinical Cancer Research · 77
PDF
LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer
2023 · Jiali Dai, Tianyu Qu, et al. · Cell Death and Disease · 104
PDF
Gene amplification-driven lncRNA SNHG6 promotes tumorigenesis via epigenetically suppressing p27 expression and regulating cell cycle in non–small cell lung cancer
2022 · Qi Wang, Wei Zhang, et al. · Cell Death Discovery · 20
PDF
MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc–Mediated Cell-Cycle Progression and Proliferation in Lung Cancer
2022 · Qingqing Zhu, Chongguo Zhang, et al. · Cancer Research · 95
EZH2-mediated epigenetic suppression of lncRNA PCAT18 predicts a poor prognosis and regulates the expression of p16 by interacting with miR-570a-3p in gastric cancer
2021 · Liangjun Zhu, Chongguo Zhang, et al. · Journal of Cancer · 14
PDF
Behouden of hervormen? Crisismanagement binnen het gevangeniswezen
2006 · S.L. Resodihardjo
Year
Topic